Bristol-Myers Squibb (Germany) Today
| BRM Stock | EUR 46.26 0.05 0.11% |
Performance1 of 100
| Odds Of DistressLess than 9
|
Bristol-Myers Squibb is trading at 46.26 as of the 24th of April 2024. This is a -0.11 percent decrease since the beginning of the trading day. The stock's lowest day price was 46.04. Bristol-Myers Squibb has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. Equity ratings for Bristol Myers Squibb are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2024 and ending today, the 24th of April 2024. Click here to learn more.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. BRISTOL MYERS operates under Drug Manufacturers - Major classification in Germany and is traded on Frankfurt Stock Exchange. The company has 2.1 B outstanding shares. More on Bristol Myers Squibb
Moving against Bristol-Myers Stock
| 0.69 | DBPD | Xtrackers ShortDAX | PairCorr |
Bristol-Myers Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Bristol-Myers Squibb's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Bristol-Myers Squibb or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers - Major, Healthcare (View all Sectors) |
Bristol Myers Squibb (BRM) is traded on Frankfurt Exchange in Germany and employs 34,300 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 137.44 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bristol-Myers Squibb's market, we take the total number of its shares issued and multiply it by Bristol-Myers Squibb's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bristol Myers Squibb classifies itself under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 2.1 B outstanding shares.
Bristol Myers Squibb has accumulated about 29.36 B in cash with 13.07 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 17.95.
Check Bristol-Myers Squibb Probability Of Bankruptcy
Ownership AllocationBristol-Myers Squibb holds a total of 2.1 Billion outstanding shares. The majority of Bristol Myers Squibb outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Bristol Myers Squibb to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Bristol-Myers Squibb. Please pay attention to any change in the institutional holdings of Bristol Myers Squibb as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Bristol-Myers Ownership Details
Bristol Myers Squibb Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Bristol-Myers Squibb market risk premium is the additional return an investor will receive from holding Bristol-Myers Squibb long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Bristol-Myers Squibb. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Bristol-Myers Squibb's alpha and beta are two of the key measurements used to evaluate Bristol-Myers Squibb's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.04 | |||
| Semi Deviation | 1.22 | |||
| Standard Deviation | 1.46 | |||
| Variance | 2.12 |
Bristol-Myers Stock Against Markets
Picking the right benchmark for Bristol-Myers Squibb stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Bristol-Myers Squibb stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Bristol-Myers Squibb is critical whether you are bullish or bearish towards Bristol Myers Squibb at a given time. Please also check how Bristol-Myers Squibb's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Bristol-Myers Squibb without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
| All Next | Launch Module |
Bristol-Myers Squibb Corporate Management
Elected by the shareholders, the Bristol-Myers Squibb's board of directors comprises two types of representatives: Bristol-Myers Squibb inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bristol-Myers. The board's role is to monitor Bristol-Myers Squibb's management team and ensure that shareholders' interests are well served. Bristol-Myers Squibb's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bristol-Myers Squibb's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jitendra Tyagi | Head India | Profile | |
| Cari Gallman | VP Officer | Profile | |
| David Elkins | Ex CFO | Profile | |
| Giovanni MD | Chairman CEO | Profile | |
| BCH BM | Ex Devel | Profile | |
| Greg Meyers | Ex Officer | Profile | |
| Sandra Esq | Exec Counsel | Profile |
How to buy Bristol-Myers Stock?
Before investing in Bristol-Myers Squibb, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Bristol-Myers Squibb. To buy Bristol-Myers Squibb stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Bristol-Myers Squibb. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Bristol-Myers Squibb stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Bristol Myers Squibb stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Bristol Myers Squibb stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Bristol Myers Squibb, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Bristol-Myers Stock please use our How to Invest in Bristol-Myers Squibb guide.
Already Invested in Bristol Myers Squibb?
The danger of trading Bristol Myers Squibb is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Bristol-Myers Squibb is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Bristol-Myers Squibb. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Bristol Myers Squibb is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Bristol Myers Squibb offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bristol-Myers Squibb's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bristol Myers Squibb Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bristol Myers Squibb Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bristol Myers Squibb. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Bristol-Myers Stock please use our How to Invest in Bristol-Myers Squibb guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for Bristol-Myers Stock analysis
When running Bristol-Myers Squibb's price analysis, check to measure Bristol-Myers Squibb's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol-Myers Squibb is operating at the current time. Most of Bristol-Myers Squibb's value examination focuses on studying past and present price action to predict the probability of Bristol-Myers Squibb's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol-Myers Squibb's price. Additionally, you may evaluate how the addition of Bristol-Myers Squibb to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |